Advisory Committees

Slides for the September 15, 2010 Meeting of the Endocrinologic and Metabolic Drugs Advisory Committee

Persons with disabilities having problems accessing the PDF file(s) below may call (301) 796-3634 for assistance

FDA

FDA Core Presentations, MERIDIA (Sibutramine Hydrochloride Monohydrate), for the September 15, 2010 Meeting of the Endocrinologic and Metabolic Drugs Advisory Committee:

Eric Colman, M.D., Deputy Director, Division of Metabolism and Endocrinology Products (DMEP), Office of Drug Evaluation (ODE) II, Office of New Drugs (OND), CDER, FDA - Morning Slides (PDF - 52KB)

Vicky Borders-Hemphill, Pharm.D. CDR, Division of Epidemiology (DEPI), Office of Surveillance and Epidemiology (OSE), CDER, FDA (PDF - 87KB)

Simone P. Pinheiro, Sc.D., M.Sc., DEPI, OSE, CDER, FDA (PDF - 86KB)

Jo Wyeth, Pharm.D., Division of Pharmacovigilance (DPV) I, OSE, CDER, FDA (PDF - 39KB)

Joyce Weaver, Pharm.D., Division of Risk Management (DRISK), OSE, CDER, FDA (PDF - 64KB)

Monique Falconer, M.D., DMEP, ODE II, OND, CDER, FDA (PDF - 752KB)

Eric Colman, M.D., Deputy Director, DMEP, ODE II, OND, CDER, FDA Afternoon Slides (PDF – 1.08MB)

Sponsor

Abbott Laboratories Core Presentation, MERIDIA (Sibutramine Hydrochloride Monohydrate), for the September 15, 2010 Meeting of the Endocrinologic and Metabolic Drugs Advisory Committee (PDF - 867KB)

Open Public Hearing Slide Presentations

Morgan Downey, J.D., The Downey Obesity Report (PDF – 295KB)

Aldo Tinoco, M.D., M.P.H., Public Citizen, presenting on behalf of Sidney Wolfe, M.D., Public Citizen (PDF – 49KB)

Advisory Committees

Section Contents Menu

Committees & Meeting Materials

Slides for the September 15, 2010 Meeting of the Endocrinologic and Metabolic Drugs Advisory Committee

Links on this page: